Recent Advances in AIDS and HIV Research
艾滋病和艾滋病毒研究的最新进展
基本信息
- 批准号:8719012
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAdministratorAdvertisingAreaAwardBiometryClinicalCollaborationsCommunicationCountryDevelopmentEnvironmentEthnic groupFosteringFundingFunding OpportunitiesFutureHIVHIV InfectionsIndividualInfectionInstitutesInstitutionInternetInvestigationLeadershipLinkLocationMalignant NeoplasmsNational Institute of Mental HealthOutcomeParticipantPreventionResearchResearch PersonnelScholarshipSiteStagingSystemTravelUnited States National Institutes of HealthUniversitiesVaccinesViralWomanbasebehavioral/social sciencecareercontinuing medical educationhealth disparityinterestmeetingsnext generationposterspreferenceprogramsresearch and developmentsymposiumworking group
项目摘要
Description (as provided by the applicant): Since 1998, the NIH-funded Centers for AIDS Research (CFAR) have hosted an annual one day National CFAR Scientific Symposium in conjunction with the annual CFAR Directors'/Administrators' meeting. The purpose of the CFAR scientific symposium is to present, in a public forum, recent "cutting edge" advances in HIV/AIDS research for an average attendance of approximately 250-300. The intimate size of the meeting promotes opportunities for interactions between young and more senior investigators that would not be available at the larger annual scientific meetings related to HIV/AIDS. The meeting location rotates so that it is hosted each year by a different CFAR site. This provides geographic diversity for the venue and opportunities for a broader array of participants than for similar research symposia. As has been done for the past fifteen years, one of several AIDS-related research areas is the focus of the annual symposium. In 2011, the Duke University CFAR hosted the 15th Annual CFAR Research Symposium with focus on five scientific areas: "Host-Viral Interactions during HIV Infection", "HIV-Associated Malignancies and Co-Infections", "Emerging Vaccine Strategies", "HIV/AIDS Health Disparities", and "Approaches to an HIV Cure". Speakers were selected from the various NIH-funded Centers for AIDS Research leadership, their scientific membership, and from nationally and internationally recognized research institutions. In addition to the participating CFAR Directors and invited leaders in the field, the remaining participants for the annual National CFAR Symposia are chosen based on specific criteria. First preference is given to young investigators who have received developmental funds from an NIH-funded CFAR program; second preference to young investigators with demonstrable potential in HIV/AIDS research; third preference is to other senior investigators engaged in HIV/AIDS research. In all cases women and individuals from underrepresented ethnic groups are encouraged to attend through targeted advertising and travel scholarships. Continuing Medical Education credits have been offered for attendees and access to web casts of the symposia are now available for interested investigators who are not able to attend.
描述(由申请人提供):自 1998 年以来,NIH 资助的艾滋病研究中心 (CFAR) 与年度 CFAR 主任/管理员会议一起主办了一年一度的为期一天的全国 CFAR 科学研讨会。 CFAR 科学研讨会的目的是在公共论坛上展示艾滋病毒/艾滋病研究的最新“前沿”进展,平均出席人数约为 250-300 人。会议规模的亲密性促进了年轻研究人员和高级研究人员之间的互动机会,而这些机会是在与艾滋病毒/艾滋病相关的大型年度科学会议上所无法获得的。会议地点会轮换,每年由不同的 CFAR 站点主办。与类似的研究研讨会相比,这为会场提供了地理多样性,并为更广泛的参与者提供了机会。正如过去十五年所做的那样,与艾滋病相关的几个研究领域之一是年度研讨会的焦点。 2011年,杜克大学CFAR主办了第15届年度CFAR研究研讨会,重点讨论五个科学领域:“HIV感染期间宿主与病毒的相互作用”、“HIV相关恶性肿瘤和合并感染”、“新兴疫苗策略”、“HIV/AIDS健康差异”和“HIV治愈方法”。演讲者是从美国国立卫生研究院资助的各个艾滋病研究中心的领导层、其科学成员以及国内和国际公认的研究机构中选出的。除了参与的 CFAR 主任和受邀的该领域的领导者之外,年度全国 CFAR 研讨会的其余参与者也是根据特定标准选出的。首先优先考虑从 NIH 资助的 CFAR 计划中获得发展资金的年轻研究人员;第二优先考虑在艾滋病毒/艾滋病研究方面具有明显潜力的年轻研究人员;第三优先是其他从事艾滋病毒/艾滋病研究的高级研究人员。在所有情况下,都通过有针对性的广告和旅行奖学金鼓励来自代表性不足的族裔群体的妇女和个人参加。已经为与会者提供了继续医学教育学分,并且现在可以为无法参加的感兴趣的研究人员提供研讨会的网络广播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL A VOLBERDING其他文献
PAUL A VOLBERDING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL A VOLBERDING', 18)}}的其他基金
UCSF-GIVI Center for AIDS Research: EARLI Study Arm B Supplement
UCSF-GIVI 艾滋病研究中心:EARLI 研究组 B 补充材料
- 批准号:
8335653 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 1.5万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 1.5万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 1.5万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 1.5万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 1.5万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 1.5万 - 项目类别:














{{item.name}}会员




